Clinical use of hematopoietic stem cells

Mutlu Arat

DOI: 10.5606/fng.transplantasyon.2016.003

Issue: 2016, Volume 1 - Issue 1
0 960

Let’s familiarize ourselves with the stem cell

Utku Ateş

DOI: 10.5606/fng.transplantasyon.2016.004

Issue: 2016, Volume 1 - Issue 1
0 5726

Mesenchymal stem cell

Işık Akgün

DOI: 10.5606/fng.transplantasyon.2016.005

Issue: 2016, Volume 1 - Issue 1
0 1514

Is organ transplantation possible without immunosuppressive drugs

Mine Ün, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.005

Issue: 2018, Volume 3 - Issue 1-2
0 763

Propranolol and cancer

Zehra Pınar Cengiz, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.008

Issue: 2018, Volume 3 - Issue 1-2
0 727

Relationship of sleep, melatonin, and cancer

Ali Çimen, Yasemin Akbaş, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.009

Issue: 2018, Volume 3 - Issue 1-2
0 1903

Natural health products that inhibit tumoral angiogenesis

Emin Taşkıran, Harun Akar, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2017.001

Issue: 2017, Volume 2 - Issue 1
0 635

Hematopoietic stem cell transplantation in benign hematological diseases

Mehmet Can Uğur, Emin Taşkıran, Harun Akar

DOI: 10.5606/fng.transplantasyon.2017.003

Issue: 2017, Volume 2 - Issue 1
0 526

Cancer immunotherapy

Ahmet Anıl Özlük, Merve Güner Oytun, Damla Günenç

DOI: 10.5606/fng.transplantasyon.2017.004

Issue: 2017, Volume 2 - Issue 1
0 1173

Current mesenchymal stem cell applications with regard to clinical studies

Yonca Erdal, Umut Doğu Seçkin

DOI: 10.5606/fng.transplantasyon.2017.009

Issue: 2017, Volume 2 - Issue 2
0 1048

The role of angiogenesis in physiological and pathological conditions

Rasim Hamutoğlu, Ozan Önder

DOI: 10.5606/fng.transplantasyon.2017.010

Issue: 2017, Volume 2 - Issue 2
0 835

Non-small cell lung cancer and its treatment

Havvanur Akbulut, Semanur İncedayı, Özüm Atasoy

DOI: 10.5606/dsufnjt.2019.004

Issue: 2019, Volume 4 - Issue 1-2
665 524

Urinary tumor markers for diagnosis of prostate cancer

Mine Ün, Mustafa Sel

DOI: 10.5606/dsufnjt.2019.010

Issue: 2019, Volume 4 - Issue 1-2
622 506

Repigmentation observed in hair due to cancer immunotherapy

Esra Nur Arslan, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.004

Issue: 2018, Volume 3 - Issue 1-2
649 405

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019

Issue: 2021, Volume 6 - Issue 1-2
0 269

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023

Issue: 2021, Volume 6 - Issue 1-2
0 224

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024

Issue: 2021, Volume 6 - Issue 1-2
0 326

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029

Issue: 2021, Volume 6 - Issue 1-2
0 249